Duo launch biopharma industry news service
Two former managers of FierceMarkets who built its life sciences vertical from a tiny email newsletter into a profitable multimillion dollar venture, have recently struck out on their own.
Endpoints is producing two email newsletters per day — an early edition with mostly links and quick hit aggregation at 7 a.m., and and a feature edition at noon, which contains its news stories, perhaps four to six in a day.
The news service is being run by Arsalan Arif, the former publisher of FierceMarkets’ life sciences division who is editor of its Early Edition email and regularly contributes news reports to Endpoints, and John D. Carroll, who was editor of FierceBiotech from 2003 to 2016.
“Our website has our original stories and Marco, our newsbot that uncovers and ranks all the best stories on Twitter that drug developers ought to see,” said Arif in an email to Talking Biz News.
The content is currently free. Arif said the market for Endpoints is the 100,000 to 150,000 people in the biopharma industry.
Carroll spent six years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times.